Janon, Sendoy .

HRN: 22-39-72  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
OXACILLIN 500MG (VIAL)
09/07/2023
09/13/2023
IVT
175mg
Q6hrs
Bacterial Skin Infection; Pcap C
Waiting Final Action 
09/08/2023
MUPIROCIN 2%, 15G (TUBE)
09/08/2023
09/15/2023
TOPICAL
15g
Bid
Bacterial Skin Infection
Waiting Final Action 
09/09/2023
CEFUROXIME 750MG (VIAL)
09/09/2023
09/15/2023
IV DRIP
230 Mg
Q8
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: